NYCBS Cancer Biorepository Collects Patient Samples
Summary
New York Cancer and Blood Specialists (NYCBS) registered an observational biorepository study on ClinicalTrials.gov under NCT07543159. The study collects and stores biological samples and clinical data from cancer patients, high-risk populations, and survivors to support translational cancer research. Samples will be used to understand cancer progression and develop new therapies.
What changed
This document registers NCT07543159, a new observational study by New York Cancer and Blood Specialists, on ClinicalTrials.gov. The study establishes a longitudinal biospecimen repository collecting samples and clinical data from thousands of cancer patients, high-risk individuals, and survivors over the course of treatment. Researchers will access banked samples and associated data to study cancer progression and support development of new therapeutic approaches.
Healthcare providers, clinical researchers, and oncology practices conducting similar biospecimen banking activities do not face direct compliance obligations from this registration. The entry serves as a public record of the study's existence and design parameters rather than imposing regulatory requirements on third parties.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Clinical Biospecimen Collection
Observational NCT07543159 Kind: OBSERVATIONAL Apr 21, 2026
Abstract
New York Cancer and Blood Specialists(NYCBS) is dedicated to provide world-class, patient-centered, affordable care to patients with cancer and blood disorders in their own communities, close to family and friends. Our vision is a world free of cancer and blood disorders by contributing to the search for cures by offering cutting-edge clinical trials and personalized, state-of-the-art treatments that save and prolong lives. In support of these objectives NYCBS has created a centralized oncology biorepository in tandem with a longitudinal study to support translational research. This study establishes a biological sample bank and associated data reservoir from thousands of cancer patients, high risk populations, and survivors. This means it collects and stores samples and information over time, throughout the course of a patient's cancer treatment. Researchers will then use these samples and information to better understand how cancer affects the body over time in order to formulate new treatments. The information and samples provided will allow the testing of new therapies and aid in the development of new medical treatments.
Conditions: Cancer Risk
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.